Vantage Consulting Group Inc
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 11, 2026), Vantage Consulting Group Inc reported 3 stock positions worth $19.7 million. Its top holding was Babcock & Wilcox Enterpr (BW) at 77.7% of the portfolio, followed by Adc Therapeutics (ADCT, 12.2%) and Cibus (CBUS, 10.1%). Its holdings were unchanged from Q3 2025.
- Most Recent 13F
- Q4 2025
- Location
- VIRGINIA BEACH, VA
- CIK
- 0001843547
- Portfolio Value
- $19.7M (Q4 2025)
- SEC Filing
- 0001843547-26-000002 ↗ filed Feb 11, 2026
Holdings Value
Holdings 3 stocks · $19.7M
Portfolio Sells Q3 2025 → Q4 2025
| None this quarter. | |||
Portfolio Buys Q3 2025 → Q4 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q4 2025 | 3 | $19.7M | BW, ADCT, CBUS |
| Q3 2025 | 3 | $11.2M | BW, ADCT, CBUS |
| Q2 2025 | 3 | $5.7M | BW, ADCT, CBUS |
| Q1 2025 | 4 | $5.0M | CBUS, BW, ADCT, FIBROGEN INC |
| Q4 2024 | 5 | $10.5M | BW, CBUS, ADCT, PBPB, FIBROGEN INC |
| Q3 2024 | 4 | $11.4M | BW, CBUS, ADCT, FIBROGEN INC |
| Q2 2024 | 191 | $134.6M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, BW, SSLY |
| Q1 2024 | 212 | $157.3M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, ADCT, SSLY |